Article

A retrospective analysis of drugs associated with the development of cutaneous squamous cell carcinoma reported by patients on the FDA’s adverse events reporting system

2024-02-27

Abstract excerpt

<title>Abstract</title> <p>Cutaneous squamous cell carcinoma (cSCC) is the second most common type of skin cancer arising from squamous cells of the epidermis. Most cases of cSCC have a good prognosis if detected and treated early; however, certain cases can be aggressive. The primary risk factor for cSCC is prolonged ultraviolet radiation from sun exposure, leading to DNA mutations. Other risk factors have also...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e114d3c2-ec79-5d0d-99a8-9d6953d5157d
DOI: 10.21203/rs.3.rs-3979528/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A retrospective analysis of drugs associated with the development of cutaneous squamous cell carcinoma reported by patients on the FDA’s adverse events reporting systemDOI 10.21203/rs.3.rs-3979528/v1Read

Biologic Treatment for Cutaneous Immune-Related Adverse Events in Cancer Patients Undergoing Immune-Checkpoint Therapy: A Retrospective ReviewSemantic proximity Read

Cutaneous adverse events associated with Rybrevant based on FDA Adverse Event Reporting System (FAERS) database from 2021 to 2024Semantic proximity Read

Dermatological adverse events from BRAF inhibitors: a growing problem.Semantic proximity Read

Research Progress on High-Risk Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Insights from Adverse Drug Reaction Database MiningSemantic proximity Read

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort studySemantic proximity Read

Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA DatabaseSemantic proximity Read

Prediction and treatment of skin adverse reactions related to inhibitors at immune checkpointsSemantic proximity Read

Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral NeuropathySemantic proximity Read

Dermatologic adverse events associated with targeted therapies for melanoma.Semantic proximity Read

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read

Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature reviewSemantic proximity Read

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learningSemantic proximity Read